Can glycemic control minimize the risk of diabetic nephropathy?

Can glycemic control minimize the risk of diabetic nephropathy?

In this video, Dr. Suman Kirti, Endocrinologist, Holy Family Hospital, New Delhi talks about whether glycemic control can minimize the risk of diabetic nephropathy. Dr. Suman confirms that glycemic control can minimize the risk of diabetic nephropathy. The DCCT trial which is the largest trial for type 1 diabetes and UKPDS trial for type 2 diabetes have shown significant reductions of nephropathy by 33 % with decrease in HbA1c levels too. Reduction of HbA1c by 0.9 % can decrease nephropathy by 30%. Reduction of HbA1c levels by 2 % can cause 60% reduction of developing nephropathy. Hence, there is a huge advantage of glycemic control on diabetic nephropathy.

Get our Newsletter

Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.

Your privacy is important to us

MEDICAL AFFAIRS

CONTENT INTEGRITY

NEWSLETTERS

© 2022 Medtalks